Head-to-Head

Adicet Bio, Inc. Common Stock vs. Eli Lilly & Co.

ACET

Adicet Bio, Inc. Common Stock

$6.35 -29.60%

VS LLY

Eli Lilly & Co.

$1184.83 +0.12%

Eli Lilly & Co. (LLY) comes out ahead, leading on 5 of 6 compared factors.

Size & Scale

ACETLLY
Market Cap $59.45 million $1.05 trillion
Revenue (TTM) — $79.67 billion
Net Income (TTM) $-98,974,000 $26.71 billion

LLY leads on 3 of 3 size & scale factors.

Valuation

ACETLLY
P/E Ratio — 39.77
Price / Book 0.49 31.14
Price / Sales — 13.24

ACET leads on 1 of 1 valuation factors.

Profitability

ACETLLY
Net Margin — 33.53%
Return on Equity -82.38% 78.84%

LLY leads on 1 of 1 profitability factors.

Dividend

ACETLLY
Dividend Yield — 0.58%
Payout Ratio — 23.23

ACET and LLY split the dividend factors evenly.

Risk & Sentiment

ACETLLY
Short Interest 13.28% 1.29%

LLY leads on 1 of 1 risk & sentiment factors.

Dig deeper: ACET overview, ACET financials, LLY overview, LLY financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.